Table 2.
Antimicrobial Agent | CRPA | CSPA | |||
---|---|---|---|---|---|
Meropenem | Resistance Breakpoint (µg/mL) | ≥8 | |||
Resistant N(%) | 38(100) | 0 | |||
Range (µg/mL) | MIC50 | 8 to >32 | – | ||
MIC90 | 8 to >32 | – | |||
Cefepime | Resistance Breakpoint (µg/mL) | ≥32 | |||
Resistant N(%) | 33 (86.8) | 5 (16.6) | |||
Range (µg/mL) | MIC50 | 16 to >1024 | 2–32 | ||
MIC90 | 16 to >1024 | 2–32 | |||
Ceftazidime | Resistance Breakpoint (µg/mL) | ≥32 | |||
Resistant N(%) | 36 (92.1) | 11 (36.6) | |||
Range (µg/mL) | MIC50 | 32 to >1024 | 2–32 | ||
MIC90 | 64 to >1024 | 2–32 |
Abbreviations: CRPA, carbapenem-resistant P. aeruginosa; CSPA, carbapenem-susceptible P. aeruginosa.